Biotech

All Articles

Ideaya bags alternative on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is actually betting $400 thousand in biobucks that a bispecific antibody-drug co...

Takeda takes $140M reduction on failed epilepsy medication, promotes FDA operate

.Our company already know that Takeda is actually wishing to discover a course to the FDA for epilep...

VBI Vaccinations files for bankruptcy, finds property sale

.Immunology biotech VBI Vaccinations is actually diverting dangerously close to the moment of truth,...

Celldex anti-cKIT antibody minimize colonies in an additional period 2 study

.It is actually difficult to muscle mass in on a room as affordable as immunology, but Celldex Rehab...

Boehringer provides to $1.3 B for checkpoint prevention biotech

.Boehringer Ingelheim is actually providing to $1.3 billion for Nerio Therapies and a preclinical in...

Ventyx's last hope for inflammatory med ends in Crohn's failure

.Ventyx Biosciences' Crohn's health condition medicine carried out certainly not help individuals ob...

Cognition's phase 2 radiate records tarnish Alzheimer's prospect

.Knowledge Rehabs' phase 2 sparkle trial has taken some of the luster off the Alzheimer's health con...

BMS axes bispecific months after filing to operate phase 3 test

.Bristol Myers Squibb has possessed a whiplash change of mind on its own BCMA bispecific T-cell enga...

Charles Baum manages Terremoto as chief executive officer

.Charles Baum, M.D., Ph.D., that supervised Mirati Therapeutics' $ 5.8 billion sale to Bristol Myers...

Asarina to shut after efforts to partner Tourette's medication stop working

.After connecting to greater than 200 companies to partner a Tourette disorder treatment that showed...